Synthesis and pharmacological validation of a novel radioligand for the orphan GPR88 receptor

Bioorg Med Chem Lett. 2023 Jan 15:80:129120. doi: 10.1016/j.bmcl.2022.129120. Epub 2022 Dec 29.

Abstract

GPR88 is an orphan G protein-coupled receptor which has been implicated in a number of striatal-associated disorders. Herein we describe the synthesis and pharmacological characterization of the first GPR88 radioligand, [3H]RTI-33, derived from a synthetic agonist RTI-13951-33. [3H]RTI-33 has a specific activity of 83.4 Ci/mmol and showed one-site, saturable binding (KD of 85 nM) in membranes prepared from stable PPLS-HA-hGPR88-CHO cells. A competition binding assay was developed to determine binding affinities of several known GPR88 agonists. This radioligand represents a powerful tool for future mechanistic and cell-based ligand-receptor interaction studies of GPR88.

Keywords: GPR88; Radioligand binding; [(3)H]RTI-33.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Carrier Proteins*
  • Cricetinae
  • Cricetulus
  • Radioligand Assay
  • Receptors, G-Protein-Coupled* / agonists

Substances

  • Receptors, G-Protein-Coupled
  • Carrier Proteins